- Encysive Pharmaceuticals Blind-Sided: Thelin Receives Approvable Letter from FDA
- FDA Delay of Tysabri Verdict Not a Surprise (BIIB, ELN)
- Nabi Biopharmaceuticals Continues Clinical Development of StaphVax (NABI)
- Tysabri Comes Out On Top At FDA Panel Meeting (BIIB, ELN)
- Tysabri To Be Discussed At FDA Advisory Committee Meeting: Findings From The Briefing Documents (BIIB, ELN)
This user currently has no profile.
BioBlogger is a contributor to Seeking Alpha.
Currently, you have no snapshot. Click edit to add details such as trading frequency and investing interests.
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.
Latest comments on BioBlogger's Articles
LATEST ARTICLES & INSTAPOSTS more »